NFL Biosciences Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Public

  • Employees
  • 5

Employees

  • Stock Symbol
  • ALNFL

Stock Symbol

  • Share Price
  • $0.39
  • (As of Friday Closing)

NFL Biosciences General Information

Description

NFL Biosciences SA specializes in the research and development of medicines to combat tobacco addiction that use botanical and pharmaceutical agents. NFL-101 is company's core product, targeting smoking addiction. It is a clinically developed, botanical drug that contains an insignificant amount of nicotine and is composed of well characterized, natural tobacco leaf proteins.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly Angel backed
Corporate Office
  • 199 rue Helene Boucher
  • Castelnau-le-lez
  • 34170 Montpellier
  • France
+33 04
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
PAR
Corporate Office
  • 199 rue Helene Boucher
  • Castelnau-le-lez
  • 34170 Montpellier
  • France
+33 04

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NFL Biosciences Stock Performance

As of 13-Nov-2026, NFL Biosciences’s stock price is $0.39. Its current market cap is $4.94M with 12.7M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.39 $0.42 $0.38 - $2.19 $4.94M 12.7M 50.7K -$0.28

NFL Biosciences Financials Summary

As of 30-Jun-2026, NFL Biosciences has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 10,740 13,896 15,865 8,263
Revenue 0 0 0 0
EBITDA (4,257) (4,273) (2,939) (4,484)
Net Income (3,547) (3,743) (2,252) (4,053)
Total Assets 5,530 4,303 3,756 4,389
Total Debt 3,732 684 43 69
Public Fundamental Data provided by Morningstar, Inc. disclaimer

NFL Biosciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore NFL Biosciences‘s full profile, request access.

Request a free trial

NFL Biosciences Patents

NFL Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4608428-A2 Methods of treatment involving tobacco leaf extracts to help smoking cessation Pending 24-Oct-2022
US-20260166111-A1 Methods of treatment involving tobacco leaf extracts to help smoking cessation Pending 24-Oct-2022
WO-2024089465-A2 Methods of treatment involving tobacco leaf extracts to help smoking cessation Inactive 24-Oct-2022
WO-2024089465-A3 Methods of treatment involving tobacco leaf extracts to help smoking cessation Inactive 24-Oct-2022
FR-3049866-A1 Extract of tobacco leaves and use for treatment of tobacco addiction Active 07-Apr-2016 A61K36/81
To view NFL Biosciences’s complete patent history, request access »

NFL Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NFL Biosciences ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view NFL Biosciences’s complete esg history, request access »

NFL Biosciences FAQs

  • When was NFL Biosciences founded?

    NFL Biosciences was founded in 2006.

  • Where is NFL Biosciences headquartered?

    NFL Biosciences is headquartered in Montpellier, France.

  • What is the size of NFL Biosciences?

    NFL Biosciences has 5 total employees.

  • What industry is NFL Biosciences in?

    NFL Biosciences’s primary industry is Drug Discovery.

  • Is NFL Biosciences a private or public company?

    NFL Biosciences is a Public company.

  • What is NFL Biosciences’s stock symbol?

    The ticker symbol for NFL Biosciences is ALNFL.

  • What is the current stock price of NFL Biosciences?

    As of 13-Nov-2026 the stock price of NFL Biosciences is $0.39.

  • What is the current market cap of NFL Biosciences?

    The current market capitalization of NFL Biosciences is $4.94M.

  • What is NFL Biosciences’s annual earnings per share (EPS)?

    NFL Biosciences’s EPS for 12 months was -$0.28.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process